This analysis of National Cardiovascular Data Registry CathPCI Registry data compares the current use and outcomes of unprotected left main percutaneous coronary intervention with results reported in clinical trials.
This study examines temporal trends and comparative outcomes of routine manual aspiration thrombectomy during primary percutaneous coronary intervention for ST-segment elevation myocardial infarction.
This cohort study investigates whether rates of uninsurance among patients hospitalized for acute myocardial infarction (AMI) and in-hospital care and outcomes changed 3 years after states elected to expand Medicaid compared with nonexpansion states.
This cost-effectiveness analysis estimates the lifetime costs and quality-adjusted life-years associated with adding canakinumab to standard of care for the secondary prevention of major cardiovascular events.
This phenome-wide association study determines polygenic predictors of thyrotropin levels and atrial fibrillation.
This mendelian randomization study evaluates the relationship between thyroid traits and atrial fibrillation.
This study examines center-level variation in Medicare spending for durable left ventricular assist device implant hospitalizations and its association with clinical outcomes.
This analysis of data from the Emerging Risk Factors Collaboration and the UK Biobank estimates the associations of major cardiovascular risk factors with venous thromboembolism.
This observational study assesses the association of high levels of physical activity, prevalent coronary artery calcification, and subsequent mortality risk among patients from a preventive medicine clinic with varying levels of physical activity.
This Viewpoint discusses the use of electrocardiogram screening for atrial fibrillation, particularly in light of the US Preventive Services Task Force’s “insufficient evidence” recommendation regarding screening.
This article describes the death of an 87-year-old woman during surgery and suggests possible improvements to end-of-life decision making in this context.
This Editorial argues for the total cessation of clinical trials investigating cardiac stem cells because foundational data has been revealed as fraudulent and previous clinical trials as largely without positive result.
A 63-year-old woman with atrial fibrillation and a history of atrial septal defect and ventricular septal defect presents with right frontal lobe abscess with vasogenic edema. What would you do next?
This case report describes a woman in her 40s who presented with midsternal, pressurelike chest pain.
Create a personal account or sign in to: